Monitoring the Release of Methylglyoxal (MGO) from Honey and Honey-Based Formulations.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
22 Mar 2023
Historique:
received: 17 02 2023
revised: 16 03 2023
accepted: 20 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Methylglyoxal (MGO) is considered to be one of the vital components responsible for the anti-bacterial activity of

Identifiants

pubmed: 36985830
pii: molecules28062858
doi: 10.3390/molecules28062858
pmc: PMC10051060
pii:
doi:

Substances chimiques

Pyruvaldehyde 722KLD7415
Magnesium Oxide 3A3U0GI71G
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : University of Western Australia
ID : University Postgraduate Award (UPA)

Références

Pharm Res. 2007 Dec;24(12):2207-12
pubmed: 17665289
Hong Kong Med J. 2007 Oct;13(5):382-6
pubmed: 17914145
J Altern Complement Med. 2003 Apr;9(2):267-73
pubmed: 12804080
PLoS One. 2016 Nov 18;11(11):e0167006
pubmed: 27861622
Carbohydr Res. 2008 Mar 17;343(4):651-9
pubmed: 18194804
PLoS One. 2011 Mar 28;6(3):e18229
pubmed: 21464891
Foods. 2022 Jun 27;11(13):
pubmed: 35804717
Int J Pharm. 2016 Oct 15;512(1):234-241
pubmed: 27568498
Bioengineering (Basel). 2018 Jun 14;5(2):
pubmed: 29903998
BMC Complement Altern Med. 2009 Sep 15;9:34
pubmed: 19754926
J Microbiol Methods. 2022 Nov;202:106596
pubmed: 36210022
Am J Clin Dermatol. 2011 Jun 1;12(3):181-90
pubmed: 21469763
J Appl Microbiol. 2002;93(5):857-63
pubmed: 12392533
Drug Dev Ind Pharm. 2011 Feb;37(2):178-84
pubmed: 21073322
Antibiotics (Basel). 2022 Jul 20;11(7):
pubmed: 35884229
Asian Pac J Trop Biomed. 2011 Apr;1(2):154-60
pubmed: 23569748
AAPS PharmSciTech. 2011 Jun;12(2):782-94
pubmed: 21688063
J Am Acad Dermatol. 2008 Feb;58(2):185-206
pubmed: 18222318
J Tissue Viability. 2016 May;25(2):98-118
pubmed: 26852154
Int J Nanomedicine. 2012;7:753-62
pubmed: 22393284
Am J Clin Dermatol. 2017 Apr;18(2):237-251
pubmed: 28063093
Front Pharmacol. 2017 Jun 28;8:412
pubmed: 28701955
Am J Clin Dermatol. 2001;2(1):13-9
pubmed: 11702616

Auteurs

Md Lokman Hossain (ML)

Division of Pharmacy, School of Allied Health, University of Western Australia, Crawley 6009, Australia.

Lee Yong Lim (LY)

Division of Pharmacy, School of Allied Health, University of Western Australia, Crawley 6009, Australia.

Katherine Hammer (K)

School of Biomedical Sciences, University of Western Australia, Crawley 6009, Australia.
Cooperative Research Centre for Honey Bee Products Limited, 128 Yanchep Beach Road, Perth 6035, Australia.

Dhanushka Hettiarachchi (D)

Division of Pharmacy, School of Allied Health, University of Western Australia, Crawley 6009, Australia.

Cornelia Locher (C)

Division of Pharmacy, School of Allied Health, University of Western Australia, Crawley 6009, Australia.
Cooperative Research Centre for Honey Bee Products Limited, 128 Yanchep Beach Road, Perth 6035, Australia.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH